AGENTUS THERAPEUTICS, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • September 14th, 2021 • MiNK Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 14th, 2021 Company IndustryThis agreement (this “Agreement”) evidences the grant of shares of Restricted Stock by AgenTus Therapeutics, Inc. (the “Company”) to the individual named above (the “Grantee”), pursuant to and subject to the terms of the AgenTus Therapeutics, Inc. 2018 Equity Incentive Plan (as amended from time to time, the “Plan”). Except as otherwise defined herein, all capitalized terms used herein have the same meaning as in the Plan.
AGENTUS THERAPEUTICS, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • September 14th, 2021 • MiNK Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 14th, 2021 Company IndustryThis agreement (this “Agreement”) evidences the grant of shares of Restricted Stock by AgenTus Therapeutics, Inc. (the “Company”) to the individual named above (the “Grantee”), pursuant to and subject to the terms of the AgenTus Therapeutics, Inc. 2018 Equity Incentive Plan (as amended from time to time, the “Plan”). Except as otherwise defined herein, all capitalized terms used herein have the same meaning as in the Plan.